Purpose
CDC has developed and published syndromic surveillance messaging guides. These guides support Promoting Interoperability programs that employ health information technology to improve the quality and value of American health care.
Standards
To access and use the implementation guides for the syndromic surveillance Promoting Interoperability objectives, please see the tables below under current and previous releases.
| Document | Transaction | Standard(s) Used | Status |
|---|---|---|---|
| PHIN Messaging Guide for Syndromic Surveillance: Emergency Department, Urgent Care, Inpatient and Ambulatory Care Settings, Release 2.0 (April, 2015)
PHIN 2.0 Implementation Guide Meaningful Use Clarifying Document (PDF available on NIST Website) |
Sending data from emergency department, urgent, ambulatory care and inpatient settings to public health authorities
Certifying 2015 Edition Meaningful Use electronic health record technology |
HL7® 2.5.1
HL7®v2 |
Published |
| Document | Transaction | Standard(s) Used | Status |
|---|---|---|---|
| HL7® Version 2.5.1 Implementation Guide: Syndromic Surveillance, Release 1 – US Realm, Standard for Trial Use, July 2019 | Syndromic surveillance is a process that regularly and systematically uses health and health-related data in near “real-time” to make information available on the health of a community. This information includes statistics on disease trends and community health-seeking behaviors that support essential public health surveillance functions in governmental public health authorities (PHAs). | HL7® Version 2.5.1,
ICD-10-CM, SNOMED-CT, LOINC, Rx Norm, UCUM, CPT4 |
Available for early adoption |
| Document | Transaction | Standard(s) Used | Status |
|---|---|---|---|
| PHIN Messaging Guide For Syndromic Surveillance: Emergency Department, Urgent Care And Inpatient Settings, Release 1.9 (April 2013) | Biosurveillance
(Currently not referenced for EHR certification) |
HL7® 2.5.1
(Version 2.3.1 Compatible) This guide is suggested for future Meaningful Use Stages. |
Published |
| PHIN Messaging Guide for Syndromic Surveillance: Emergency Department and Urgent Care Data, Release 1.1 (August 2012),Testing Clarification Release 1.2 (February 2013) | Biosurveillance
(ONC Certification Criteria for EHR Technology, 2014 Ed.) |
HL7® 2.5.1
(Version 2.3.1 Compatible) Meaningful Use Stage 2 (October 2013 start) |
Published |
| PHIN Messaging Guide for Syndromic Surveillance: Emergency Department and Urgent Care Data, Release 1.1 (August 2012) | Biosurveillance
(ONC Certification Criteria for EHR Technology, 2014 Ed.) |
HL7® 2.5.1
(Version 2.3.1 Compatible) Meaningful Use Stage 2 (October 2013 start) |
Published |
| PHIN Messaging Guide for Syndromic Surveillance: Emergency Department and Urgent Care Data, Addendum Release 1.1 (August 2012) | Biosurveillance
(ONC Certification Criteria for EHR Technology, 2014 Ed.) |
HL7® 2.5.1
(Version 2.3.1 Compatible) Meaningful Use Stage 2 (October 2013 start) |
Published |
| PHIN Messaging Guide for Syndromic Surveillance: Emergency Department and Urgent Care Data, Release 1 (October 2011) | Biosurveillance
(Suggested for use with EHR Certification 2011 ed.) |
HL7® 2.5.1
(Version 2.3.1 Compatible) |
Published |
Resources
HL7 Messaging Standard Version 2.5.1—Support the exchange, integration, sharing, and retrieval of electronic health information. Note: This guidance can be found on the Health Level Seven International website (HL7.org). Access requires setting up a user account.
National Institute for Standards and Technology (NIST) HL7 V2.5.1 Syndromic Surveillance Validation Tool – Meaningful Use 2014 Edition—Before onboarding, HL7® messages must pass this compliance check.
NIST Syndromic Surveillance Test Suite—Data validation tools.
Public Health Information Network (PHIN) Vocabulary Access and Distribution System (VADS)—Standards-based vocabulary (within PHIN systems) fosters the use and exchange of consistent information among public health partners.
- HL7® and FHIR® are the registered trademarks of Health Level Seven International, and their use of these trademarks does not constitute an endorsement by HL7.